Summit Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Hold
7,706
0.52% 30
2026
Q1
$4.33M Hold
7,706
0.6% 29
2025
Q4
$5.21M Sell
7,706
-79
-1% -$53.8K 0.74% 28
2025
Q3
$4.97M Hold
7,785
0.76% 27
2025
Q2
$4.18M Hold
7,785
0.68% 29
2025
Q1
$3.27M Hold
7,785
0.57% 31
2024
Q4
$3.22M Sell
7,785
-50
-0.6% -$21.9K 0.57% 31
2024
Q3
$3.96M Hold
7,835
0.74% 23
2024
Q2
$3.82M Hold
7,835
0.79% 22
2024
Q1
$4.23M Hold
7,835
0.91% 22
2023
Q4
$4.35M Hold
7,835
1.04% 19
2023
Q3
$3.43M Sell
7,835
-50
-0.6% -$24.9K 0.93% 20
2023
Q2
$3.96M Hold
7,885
1.04% 19
2023
Q1
$3.94M Hold
7,885
1.09% 19
2022
Q4
$3.22M Hold
7,885
0.93% 22
2022
Q3
$2.57M Sell
7,885
-9
-0.1% -$3.31K 0.83% 23
2022
Q2
$2.77M Hold
7,894
0.86% 23
2022
Q1
$4.32M Hold
7,894
1.24% 16
2021
Q4
$5.2M Sell
7,894
-127
-2% -$79.7K 1.47% 13
2021
Q3
$4.99M Hold
8,021
1.56% 13
2021
Q2
$5.07M Sell
8,021
-33
-0.4% -$18.2K 1.59% 14
2021
Q1
$3.94M Buy
8,054
+9
+0.1% +$4.51K 1.34% 14
2020
Q4
$4.02M Sell
8,045
-100
-1% -$44.7K 1.47% 14
2020
Q3
$3.2M Hold
8,145
1.33% 15
2020
Q2
$2.69M Hold
8,145
1.22% 15
2020
Q1
$1.97M Sell
8,145
-100
-1% -$26.1K 1.06% 15
2019
Q4
$2.15M Hold
8,245
0.92% 16
2019
Q3
$2.24M Hold
8,245
1.04% 15
2019
Q2
$2.27M Hold
8,245
1.08% 15
2019
Q1
$1.84M Hold
8,245
0.91% 19
2018
Q4
$1.53M Hold
8,245
0.87% 19
2018
Q3
$2.06M Hold
8,245
0.95% 17
2018
Q2
$1.8M Hold
8,245
0.86% 19
2018
Q1
$1.58M Hold
8,245
0.75% 23
2017
Q4
$1.29M Sell
8,245
-200
-2% -$31.5K 0.62% 26
2017
Q3
$1.31M Hold
8,445
0.66% 25
2017
Q2
$1.36M Hold
8,445
0.72% 25
2017
Q1
$1.31M Hold
8,445
0.76% 25
2016
Q4
$990K Sell
8,445
-300
-3% -$34.2K 0.62% 26
2016
Q3
$986K Hold
8,745
0.61% 27
2016
Q2
$812K Sell
8,745
-841
-9% -$72.2K 0.52% 31
2016
Q1
$751K Hold
9,586
0.49% 35
2015
Q4
$699K Hold
9,586
0.47% 35
2015
Q3
$712K Hold
9,586
0.51% 35
2015
Q2
$615K Hold
9,586
0.42% 42
2015
Q1
$740K Hold
9,586
0.52% 35
2014
Q4
$711K Hold
9,586
0.51% 33
2014
Q3
$565K Hold
9,586
0.43% 37
2014
Q2
$640K Hold
9,586
0.49% 33
2014
Q1
$582K Hold
9,586
0.47% 35
2013
Q4
$510K Buy
9,586
+186
+2% +$9.79K 0.4% 38
2013
Q3
$468K Sell
9,400
-400
-4% -$19.2K 0.42% 38
2013
Q2
$439K Buy
+9,800
New +$428K 0.42% 34

Other funds holding IDXX

Summit Asset Management's IDXX Position: Q2 2026 in Review

Summit Asset Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 7,706 shares worth $4.06M. The position accounts for 0.52% of the portfolio, ranked #30.

Summit Asset Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.21M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Summit Asset Management held 7,706 shares of Idexx Laboratories worth $4.06M as of Q2 2026.
  • Summit Asset Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.52% of Summit Asset Management's portfolio in Q2 2026, its #30 holding.
  • Summit Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Summit Asset Management's Idexx Laboratories position peaked at $5.21M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Summit Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.